Calf Septicemia and Colibacillosis

Calf septicemia and colibacillosis is a severe, often fatal, systemic disease of neonatal calves (typically within the first 7-10 days of life) caused by the invasion and proliferation of pathogenic bacteria, most commonly Escherichia coli, in the bloodstream. The condition is characterized by a systemic inflammatory response syndrome (SIRS), endotoxemia, and multi-organ dysfunction, often leading to rapid death. Colibacillosis specifically refers to the enteric and systemic infections caused by E. coli, including enterotoxigenic E. coli (ETEC) causing neonatal diarrhea, and septicemic E. coli strains that invade the bloodstream. The disease is a major cause of morbidity and mortality in dairy and beef calves worldwide, resulting in significant economic losses due to death, treatment costs, and reduced future productivity. The condition is classified into three main forms: septicemic (systemic invasion), enteric (diarrhea), and enterotoxigenic (toxin-mediated diarrhea). The septicemic form is the most severe, with high mortality rates, and is the focus of this entry. The disease is most prevalent in calves with failure of passive transfer (FPT) of maternal immunoglobulins, inadequate colostrum intake, and poor environmental hygiene. The economic impact includes direct losses from calf mortality, veterinary costs, and long-term effects on growth and milk production in surviving animals.

The primary causative agent of calf septicemia and colibacillosis is Escherichia coli, a Gram-negative, facultative anaerobic bacillus. Pathogenic strains possess various virulence factors that enable them to cause disease. These include: 1) Adhesins (e.g., F5 (K99), F41, F17, and CS31A fimbriae) that facilitate attachment to intestinal epithelial cells, leading to enteric disease; 2) Enterotoxins (heat-labile LT and heat-stable STa and STb) that cause secretory diarrhea; 3) Verotoxins (Shiga-like toxins) that damage vascular endothelium; 4) Invasive factors that allow systemic spread; and 5) Lipopolysaccharide (LPS) endotoxin, a component of the outer membrane, which triggers a massive inflammatory response. Other bacteria can also cause septicemia in calves, including Salmonella spp., Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Trueperella pyogenes, but E. coli is the most common. The source of infection is typically the environment, including contaminated bedding, feces, and the dam's perineal area. Calves are exposed during birth or shortly after, and the bacteria enter through the oral route, respiratory tract, umbilicus, or compromised intestinal mucosa. In septicemic colibacillosis, the bacteria invade the bloodstream directly, often without prior diarrhea, and multiply in various organs, including the liver, lungs, kidneys, and joints. The severity of disease is influenced by the bacterial load, virulence, and the calf's immune status, particularly the level of maternal antibodies absorbed from colostrum.

Calf septicemia and colibacillosis occurs worldwide and affects both dairy and beef calves. The incidence is highest in the neonatal period, with most cases occurring within the first 3-5 days of life, and the risk decreases significantly after 10 days of age. Dairy calves are at higher risk due to intensive management practices, such as early separation from the dam, pooled colostrum feeding, and group housing. Beef calves are also affected, especially in calving areas with poor sanitation. The disease is more prevalent in herds with inadequate colostrum management, leading to a high prevalence of failure of passive transfer (FPT), defined as serum IgG concentration < 10 g/L (or < 1000 mg/dL) at 24-48 hours of age. Calves with FPT are 5-10 times more likely to develop septicemia. Environmental factors such as overcrowding, poor ventilation, dirty bedding, and high humidity increase the bacterial load and exposure. Seasonality is observed, with higher incidence in winter and spring, possibly due to increased confinement and stress. Morbidity rates can reach 20-50% in affected herds, and mortality rates in septicemic cases are high, often exceeding 50% despite treatment. Economic losses include death loss, treatment costs, and reduced growth and future milk production in survivors. The disease is a major concern for herd health and profitability.

The pathophysiology of calf septicemia and colibacillosis involves a complex cascade of events initiated by bacterial invasion and endotoxin release. After ingestion or inhalation of pathogenic E. coli, the bacteria colonize the intestinal tract or respiratory mucosa. In the enteric form, adhesins allow attachment to enterocytes, and enterotoxins (STa) activate guanylate cyclase, leading to increased chloride secretion and decreased sodium absorption, resulting in watery diarrhea. In the septicemic form, the bacteria penetrate the intestinal or respiratory epithelium and enter the bloodstream, possibly through M cells or damaged mucosa. Once in the blood, the bacteria multiply and release lipopolysaccharide (LPS) endotoxin. Endotoxin binds to lipopolysaccharide-binding protein (LBP) and then to CD14 and Toll-like receptor 4 (TLR4) on macrophages and other immune cells, triggering a massive release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6). This leads to systemic inflammatory response syndrome (SIRS), characterized by vasodilation, increased vascular permeability, and endothelial damage. The resulting hypotension, hypovolemia, and tissue hypoperfusion cause multi-organ failure. Endotoxin also activates the coagulation cascade, leading to disseminated intravascular coagulation (DIC), which further compromises organ function. The liver, kidneys, lungs, and central nervous system are particularly affected. In the liver, endotoxin causes hepatocellular necrosis and cholestasis. In the kidneys, it leads to acute tubular necrosis and renal failure. In the lungs, it causes acute respiratory distress syndrome (ARDS) with pulmonary edema and hemorrhage. In the brain, it can cause cerebral edema and encephalopathy. The calf's immature immune system, especially with FPT, cannot effectively clear the bacteria, leading to overwhelming infection and rapid death. The metabolic consequences include hypoglycemia, metabolic acidosis, and electrolyte imbalances, which exacerbate the clinical signs.

Several intrinsic and extrinsic factors predispose calves to septicemia and colibacillosis. Intrinsic factors include: 1) Age: Calves are most susceptible in the first week of life due to immature immune function and intestinal barrier. 2) Failure of passive transfer (FPT): Inadequate colostrum intake or poor colostrum quality results in low serum IgG levels (<10 g/L), leaving the calf vulnerable to infection. 3) Genetics: Some breeds may have higher susceptibility, but this is less significant than management. 4) Stress: Perinatal stress, such as dystocia, hypoxia, and cold stress, can impair immune function and increase susceptibility. Extrinsic factors include: 1) Colostrum management: Delayed or inadequate colostrum feeding, poor colostrum quality (low IgG concentration), and improper storage or feeding methods. 2) Environmental hygiene: Dirty calving pens, contaminated bedding, and high bacterial load in the environment. 3) Overcrowding and poor ventilation: Increased exposure to pathogens and stress. 4) Nutrition: Inadequate maternal nutrition during gestation can affect calf birth weight and immunity. 5) Management practices: Early separation from dam, pooled colostrum, and feeding contaminated milk. 6) Concurrent infections: Other neonatal diseases, such as cryptosporidiosis or rotavirus, can damage the intestinal mucosa and facilitate bacterial invasion. 7) Umbilical hygiene: Poor umbilical care can lead to omphalophlebitis and subsequent septicemia. 8) Vaccination status of the dam: Lack of maternal vaccination against E. coli can reduce colostral antibody levels.

Clinical signs of calf septicemia and colibacillosis vary depending on the form and severity. In the peracute septicemic form, calves may be found dead without prior signs. In acute cases, signs include: 1) Depression and lethargy: The calf is weak, reluctant to move, and may be recumbent. 2) Fever: Initially, there is a high fever (104-107°F, 40-41.5°C), but as the disease progresses, hypothermia may develop due to endotoxic shock. 3) Dehydration: Sunken eyes, decreased skin turgor, and dry mucous membranes. 4) Tachycardia and tachypnea: Increased heart and respiratory rates. 5) Cold extremities: Due to poor peripheral perfusion. 6) Petechial and ecchymotic hemorrhages: On mucous membranes, especially the conjunctiva and oral mucosa, due to DIC. 7) Neurological signs: In severe cases, convulsions, opisthotonos, and coma may occur due to cerebral edema. 8) Joint swelling and lameness: In cases with septic arthritis, which may be a sequela. 9) Diarrhea: In the enteric form, profuse watery diarrhea, often yellowish or white, with a foul odor. 10) Decreased suckling reflex: The calf may be unable or unwilling to nurse. 11) Umbilical infection: Swelling, pain, and discharge from the umbilicus may be present. 12) Ophthalmic signs: Conjunctivitis, corneal ulcers, and uveitis may occur. The clinical course can be rapid, with death occurring within 12-24 hours in severe cases. Early recognition and treatment are critical for survival.

Differential diagnoses for calf septicemia and colibacillosis include: 1) Neonatal diarrhea (enteritis) caused by rotavirus, coronavirus, Cryptosporidium, Salmonella, or Clostridium perfringens: These typically present with diarrhea but may not have systemic signs initially. However, severe dehydration and electrolyte imbalances can lead to depression and shock. 2) Other bacterial septicemias: Salmonella spp., Mannheimia haemolytica, and Pasteurella multocida can cause similar systemic signs. Blood cultures and specific diagnostic tests are needed to differentiate. 3) Neonatal meningitis: Caused by E. coli or other bacteria, presenting with neurological signs such as seizures, opisthotonos, and coma. 4) Hypoxia/ischemia due to dystocia: Calves with perinatal asphyxia may be weak, depressed, and have poor suckling reflex, but they typically improve with supportive care. 5) Congenital abnormalities: Such as cardiac defects or diaphragmatic hernia, which may cause weakness and respiratory distress. 6) Metabolic diseases: Hypoglycemia, hypothermia, and electrolyte imbalances can cause depression and weakness. 7) Toxicity: Ingestion of toxins, such as lead or organophosphates, can cause neurological signs. 8) Trauma: Dystocia or other injuries can cause weakness and shock. 9) Omphalophlebitis: Infection of the umbilical structures can lead to systemic signs and may be a source of septicemia. 10) Bovine viral diarrhea (BVD) virus infection: Can cause immunosuppression and diarrhea, but systemic signs are less acute. Differentiation is based on history, clinical signs, laboratory tests (blood culture, fecal antigen tests, PCR), and response to treatment.

The diagnostic approach for calf septicemia and colibacillosis involves a step-by-step process: 1) Herd history: Assess colostrum management, calving environment, and recent disease outbreaks. 2) Physical examination: Evaluate hydration status, temperature, heart rate, respiratory rate, mucous membranes, and neurological status. Look for signs of septicemia, such as petechiae, joint swelling, and umbilical infection. 3) Laboratory tests: a) Complete blood count (CBC): May show leukopenia or leukocytosis with a left shift, toxic changes in neutrophils, and thrombocytopenia. b) Serum biochemistry: Hypoglycemia, azotemia (increased BUN and creatinine), elevated liver enzymes (AST, GGT), and electrolyte imbalances (hyponatremia, hyperkalemia, metabolic acidosis). c) Blood culture: Aseptically collect blood for aerobic and anaerobic culture to identify the causative organism and perform antimicrobial susceptibility testing. d) Serum IgG measurement: To assess passive transfer status. e) Fecal analysis: If diarrhea is present, test for rotavirus, coronavirus, Cryptosporidium, and E. coli (K99 antigen). 4) Imaging: Thoracic radiography or ultrasonography may reveal pneumonia or pleural effusion. Abdominal ultrasonography can assess umbilical structures and detect abscesses. 5) Necropsy: In fatal cases, necropsy findings include petechial hemorrhages on serosal surfaces, enlarged and congested liver and spleen, and evidence of DIC. 6) Response to treatment: Improvement with supportive care and antimicrobials supports the diagnosis. The algorithm emphasizes early recognition and aggressive treatment, as delays can be fatal.

Laboratory findings in calf septicemia and colibacillosis are crucial for diagnosis and prognosis. 1) Complete blood count (CBC): Leukopenia (total WBC < 4,000/μL) is common in the early stages due to endotoxin-induced neutropenia. Later, leukocytosis (WBC > 12,000/μL) with a degenerative left shift (increased band neutrophils) may occur. Toxic changes in neutrophils (cytoplasmic vacuolation, Dohle bodies) are indicative of severe infection. Thrombocytopenia (platelets < 100,000/μL) may be present due to DIC. 2) Serum biochemistry: Hypoglycemia (blood glucose < 60 mg/dL) is common due to decreased intake and increased utilization. Azotemia (BUN > 30 mg/dL, creatinine > 2.0 mg/dL) indicates renal dysfunction. Elevated liver enzymes (AST > 200 U/L, GGT > 50 U/L) suggest hepatic damage. Electrolyte imbalances include hyponatremia (Na < 135 mEq/L), hyperkalemia (K > 5.5 mEq/L), and metabolic acidosis (pH < 7.35, bicarbonate < 20 mEq/L). 3) Blood culture: Positive in 70-80% of septicemic calves if collected before antimicrobial therapy. E. coli is the most common isolate. 4) Serum IgG: < 10 g/L indicates failure of passive transfer. 5) Fecal tests: For ETEC, detection of K99 antigen by ELISA or PCR. 6) Coagulation profile: Prolonged PT and aPTT, elevated FDPs, and decreased fibrinogen indicate DIC. 7) Blood gas analysis: Metabolic acidosis with compensatory respiratory alkalosis. 8) Acute-phase proteins: Elevated serum amyloid A and haptoglobin. 9) Urinalysis: Proteinuria, hematuria, and casts may be present due to renal damage. These findings help confirm the diagnosis and guide treatment.

Imaging modalities are useful in evaluating calves with suspected septicemia and colibacillosis. 1) Thoracic radiography: May reveal interstitial or alveolar patterns indicative of pneumonia, which can be a sequela of septicemia. Pleural effusion may be seen as blunting of the costophrenic angles. 2) Thoracic ultrasonography: Can detect lung consolidation, pleural effusion, and abscesses. It is more sensitive than radiography for early changes. 3) Abdominal ultrasonography: Useful for evaluating the umbilicus and abdominal organs. In septicemia, the liver may appear enlarged and hyperechoic due to fatty infiltration or abscesses. The kidneys may show increased echogenicity due to tubular damage. The umbilicus can be assessed for omphalophlebitis, urachal remnants, and abscesses. 4) Echocardiography: May be indicated if endocarditis is suspected, but this is rare in calves. 5) Radiography of joints: In cases of septic arthritis, radiographs may show soft tissue swelling and joint space widening, but changes are often not visible until later stages. 6) Computed tomography (CT) or magnetic resonance imaging (MRI): Rarely used in practice but can provide detailed images of the brain in cases of meningitis. Imaging findings, combined with clinical signs and laboratory tests, help assess the extent of organ involvement and guide treatment decisions.

Cytological and histopathological findings are important for confirming the diagnosis and understanding the pathogenesis. 1) Blood smear cytology: May show toxic changes in neutrophils, including cytoplasmic basophilia, vacuolation, and Dohle bodies. Intracellular bacteria may be seen in severe cases. 2) Peritoneal fluid analysis: If peritonitis is suspected, abdominocentesis can be performed. The fluid may be turbid, with increased protein and nucleated cell count (> 5,000 cells/μL), predominantly neutrophils. 3) Synovial fluid analysis: In cases of septic arthritis, the fluid is turbid, with increased protein and cell count, and bacteria may be seen on Gram stain. 4) Cerebrospinal fluid (CSF) analysis: In cases of meningitis, CSF may be turbid, with increased protein and neutrophils, and bacteria may be cultured. 5) Histopathology: At necropsy, the liver shows multifocal necrosis and infiltration of neutrophils. The kidneys show acute tubular necrosis and interstitial nephritis. The lungs show interstitial pneumonia with edema and hemorrhage. The spleen is congested with lymphoid depletion. The brain may show meningitis with neutrophilic infiltration. 6) Immunohistochemistry: Can be used to detect E. coli antigens in tissues. 7) Electron microscopy: May be used to identify bacterial structures. These findings are valuable for research and for confirming the diagnosis in fatal cases.

Treatment of calf septicemia and colibacillosis is a medical emergency and requires aggressive, multi-modal therapy. The goals are to eliminate the infection, neutralize endotoxin, support organ function, and correct fluid and electrolyte imbalances. 1) Fluid therapy: Intravenous fluids are essential to correct dehydration and shock. Crystalloids such as lactated Ringer's solution or isotonic saline are given at a rate of 20-40 mL/kg over 1-2 hours for shock, then maintenance at 80-120 mL/kg/day. Hypertonic saline (7.5% NaCl) at 4-5 mL/kg IV over 5-10 minutes can be used for rapid volume expansion, followed by crystalloids. 2) Electrolyte and acid-base correction: Add sodium bicarbonate (1-2 mEq/kg IV slowly) if metabolic acidosis is severe (pH < 7.2). Monitor serum potassium and calcium. 3) Antimicrobial therapy: Broad-spectrum antibiotics should be initiated immediately after blood cultures are collected. Options include: a) Ceftiofur (2.2 mg/kg IM or SC q24h for 3-5 days); b) Ampicillin (10-20 mg/kg IV or IM q8-12h); c) Amoxicillin (10-20 mg/kg SC or IM q12h); d) Enrofloxacin (5-7.5 mg/kg SC q24h, but avoid in young calves due to cartilage damage); e) Trimethoprim-sulfadiazine (15-30 mg/kg PO or IV q12h); f) Oxytetracycline (10-20 mg/kg IV or IM q24h). The choice should be based on culture and sensitivity results. 4) Anti-inflammatory therapy: Flunixin meglumine (1.1-2.2 mg/kg IV q24h) or meloxicam (0.5 mg/kg SC or PO q48h) to reduce inflammation and fever. 5) Endotoxin neutralization: Polymyxin B (1-2 mg/kg IV q12h) can bind endotoxin, but its use is controversial. 6) Supportive care: Provide warmth, clean bedding, and nutritional support. If the calf is unable to nurse, provide milk or colostrum via bottle or tube feeding. 7) Treatment of complications: For seizures, administer diazepam (0.1-0.2 mg/kg IV) or phenobarbital (5-10 mg/kg IV). For DIC, consider heparin (50-100 U/kg SC q8h). 8) Nursing care: Monitor vital signs frequently and adjust therapy as needed. The prognosis is guarded, and early treatment is critical for survival.

The prognosis for calf septicemia and colibacillosis is guarded to poor, especially in severe cases. Factors that worsen the prognosis include: 1) Age < 3 days; 2) Failure of passive transfer (IgG < 10 g/L); 3) Presence of neurological signs; 4) Severe dehydration (> 10%); 5) Hypothermia (< 100°F, 37.8°C); 6) Leukopenia (< 2,000/μL); 7) Positive blood culture; 8) Multi-organ involvement (e.g., pneumonia, arthritis, meningitis); 9) Delay in treatment. With early and aggressive therapy, survival rates can be 50-70%, but many survivors may have long-term sequelae such as growth retardation, chronic pneumonia, or joint disease. The economic impact includes treatment costs and reduced future productivity. In herds with poor colostrum management, the prognosis is worse. Prevention through proper colostrum management and environmental hygiene is the most effective way to reduce the incidence and improve outcomes.

Follow-up care for calves that survive septicemia and colibacillosis is essential to monitor recovery and prevent complications. 1) Daily monitoring: Check temperature, heart rate, respiratory rate, hydration status, and appetite. 2) Fluid therapy: Continue IV fluids until the calf is drinking and urinating normally. 3) Antimicrobial therapy: Complete the full course of antibiotics as prescribed. 4) Nutritional support: Ensure adequate milk intake; consider feeding small, frequent meals. 5) Weight gain: Monitor weight gain weekly to ensure growth is on track. 6) Joint evaluation: If arthritis was present, monitor for lameness and joint swelling. 7) Respiratory evaluation: If pneumonia was present, monitor for coughing and abnormal lung sounds. 8) Neurological evaluation: If meningitis was present, monitor for neurological deficits. 9) Herd-level follow-up: Review colostrum management protocols, environmental hygiene, and vaccination programs. 10) Recheck serum IgG levels in other calves to assess passive transfer status. 11) Consider prophylactic antibiotics for at-risk calves? Not recommended. 12) Document outcomes and adjust management practices to prevent future cases.

Clinical pearls: 1) Early recognition is key: Any calf under 7 days old with depression, fever, and poor suckling reflex should be suspected of septicemia. 2) Blood cultures should be taken before starting antibiotics to guide therapy. 3) Aggressive fluid therapy is crucial; use hypertonic saline for rapid resuscitation. 4) NSAIDs help control inflammation and improve survival. 5) Check serum IgG in all sick calves to identify FPT. 6) In herds with recurrent colibacillosis, evaluate colostrum quality and delivery. 7) Use a sterile technique for blood collection to avoid contamination. 8) Consider polymyxin B for endotoxin neutralization in severe cases. Pitfalls: 1) Delaying treatment until the calf is moribund. 2) Using antibiotics without culture and sensitivity, leading to resistance. 3) Overlooking the importance of colostrum management. 4) Failing to correct electrolyte and acid-base imbalances. 5) Using fluoroquinolones in young calves due to cartilage damage risk. 6) Not monitoring for DIC and treating it. 7) Assuming diarrhea is the only sign; septicemia can occur without diarrhea. 8) Neglecting to check for umbilical infections. 9) Using oral antibiotics for systemic infections, as they are poorly absorbed. 10) Not providing adequate supportive care, such as warmth and nutrition.

Current drug protocols for calf septicemia and colibacillosis are based on Plumb's Veterinary Drug Handbook and AABP guidelines. 1) Fluid therapy: a) Isotonic crystalloids (Lactated Ringer's or Normosol-R): Shock dose 20-40 mL/kg IV over 1-2 hours, then maintenance 80-120 mL/kg/day. b) Hypertonic saline (7.5% NaCl): 4-5 mL/kg IV over 5-10 minutes, followed by crystalloids. c) Sodium bicarbonate (8.4% solution): 1-2 mEq/kg IV slowly, only if pH < 7.2. 2) Antimicrobials: a) Ceftiofur hydrochloride (Excenel): 2.2 mg/kg IM or SC q24h for 3-5 days. Withdrawal: meat 3 days, milk 0 days. b) Ampicillin trihydrate: 10-20 mg/kg IV or IM q8-12h. Withdrawal: meat 6 days, milk 48 hours. c) Amoxicillin trihydrate: 10-20 mg/kg SC or IM q12h. Withdrawal: meat 12 days, milk 48 hours. d) Enrofloxacin (Baytril): 5-7.5 mg/kg SC q24h for 3-5 days. Not recommended in calves < 2 weeks due to cartilage damage. Withdrawal: meat 7 days, milk 0 days. e) Trimethoprim-sulfadiazine (Tribrissen): 15-30 mg/kg PO or IV q12h. Withdrawal: meat 5 days, milk 4 days. f) Oxytetracycline (LA-200): 10-20 mg/kg IV or IM q24h. Withdrawal: meat 28 days, milk 96 hours. 3) Anti-inflammatories: a) Flunixin meglumine (Banamine): 1.1-2.2 mg/kg IV q24h for up to 3 days. Withdrawal: meat 4 days, milk 36 hours. b) Meloxicam (Metacam): 0.5 mg/kg SC or PO q48h. Withdrawal: meat 15 days, milk 5 days. 4) Endotoxin binder: Polymyxin B: 1-2 mg/kg IV q12h. Use with caution. 5) Supportive: a) Diazepam: 0.1-0.2 mg/kg IV for seizures. b) Phenobarbital: 5-10 mg/kg IV for seizures. c) Heparin: 50-100 U/kg SC q8h for DIC. 6) Nutritional support: Provide milk or colostrum at 10% of body weight per day in divided feedings. 7) Probiotics: May be used to support gut health. Always follow label directions and consult a veterinarian for specific protocols.

Evidence-based literature supports the importance of colostrum management in preventing calf septicemia and colibacillosis. Studies have shown that calves with failure of passive transfer (serum IgG < 10 g/L) have a significantly higher risk of morbidity and mortality. A landmark study by Godden et al. (2019) in the Journal of Dairy Science demonstrated that feeding 3-4 liters of high-quality colostrum within the first 2 hours of life significantly reduced the incidence of septicemia. Another study by McGuirk and Collins (2004) emphasized the use of a clinical scoring system to identify sick calves early, improving treatment outcomes. Research on antimicrobial therapy has shown that ceftiofur is effective against E. coli, but resistance is emerging. A study by Constable et al. (2017) in Veterinary Medicine recommended using NSAIDs like flunixin meglumine to improve survival in septicemic calves. The AABP (American Association of Bovine Practitioners) has published guidelines on calf health, emphasizing the importance of passive transfer and environmental hygiene. A meta-analysis by Windeyer et al. (2014) found that calves with FPT had a 2-3 times higher risk of mortality. Additionally, studies on fluid therapy have shown that hypertonic saline is effective for rapid resuscitation in endotoxic shock. Overall, the literature underscores the need for a comprehensive approach including prevention, early detection, and aggressive treatment.